Abstract:Background: Isovaleric acidaemia (IVA), characterized by an acute metabolic crisis and psychomotor delay, is a rare inherited metabolic disease caused by a deficiency in isovaleryl-CoA dehydrogenase (IVD). Methods: We report the case of a Chinese patient with IVA who was admitted to Tianjin Children's Hospital and followed up for 8 years. Genetic analysis of the patient and his parents was conducted using the whole-exome sequencing and Sanger sequencing. We searched for similar reported cases in the PubMed and Wanfang databases using the term "isovaleric acidaemia," reviewed the related literature to obtain a summary of the clinical and genetic characteristics, and analyzed the genotype–phenotype correlations. Results: The patient presented with encephalopathic symptoms, such as vomiting, lethargy, and somnolence. We identified compound heterozygous variants of the IVD gene, including the unreported variant c.224A>G (p.Asn75Ser) and the reported variant c.1195G>C (p.Asp399His). The child was prescribed a low-protein diet supplemented with L-carnitine. During the 8-year follow-up, no metabolic disorder or encephalopathic symptoms recurred. At present, the child is 11 years of age and has normal mental and motor performance. Another 154 cases identified in 25 relevant references were combined with this case, resulting in a sample of 155 patients, including 52 asymptomatic patients, 64 with neonatal onset, and 39 with the chronic intermittent disease with onset from ages of 1 month to 10 years (median age, 2 years). Among articles that reported sex, the male-to-female ratio was 1:1.06. The cardinal symptoms included vomiting, lethargy, "sweaty foot" odor, poor feeding, developmental delay, and epilepsy. The proportion of variants in regions 123–159 and 356–403 of the IVD protein was greater in symptomatic patients than in asymptomatic patients. Conversely, in asymptomatic patients, the proportion of variants in the 282–318 region was greater than in symptomatic patients. Conclusion: This case report describes an unreported variant c.224A>G (p.Asn75Ser) of the IVD gene, and summarizes previously reported cases. Furthermore, the correlation between the genotype and clinical phenotype of IVA is analyzed to improve the understanding of this disease.

Newborn screening algorithm distinguishing potential symptomatic isovaleric acidemia from asymptomatic newborns

Isovaleric aciduria identified by newborn screening: Strategies to predict disease severity and stratify treatment

Machine Learning Methods Improve Specificity in Newborn Screening for Isovaleric Aciduria

Newborn screening for isovaleric acidemia: A case report of a Chinese patient with novel variants

Application of a Next-Generation Sequencing (NGS) Panel in Newborn Screening Efficiently Identifies Inborn Disorders of Neonates

Organic acid profile of isovaleric acidemia: a comprehensive metabolomics approach

[Screening for neonatal inborn errors of metabolism by electrospray ionization-tandem mass spectrometry and follow-up].

Prenatal Diagnosis of Isovaleric Acidemia from Amniotic Fluid Using Genetic and Biochemical Approaches

Analysis of the genotype–phenotype correlation in isovaleric acidaemia: A case report of long-term follow-up of a chinese patient and literature review

Neonatal Isovaleric Acidemia in China: A Case Report and Review of Literature

Two novel isovaleryl-CoA dehydrogenase gene mutations in a Chinese infant.

[Clinical and Mutational Study of a Chinese Infant with Isovaleric Acidemia].

Effects of Birth Weight on Profiles of Dried Blood Amino-Acids and Acylcarnitines

AB054. Experiences During Newborn Screening for Glutaric Aciduria Type 1: Diagnosis, Treatment, Genotype, Phenotype and Outcomes

Comprehensive metabolomics analysis reveals novel biomarkers and pathways in falsely suspected glutaric aciduria Type-1 newborns

Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns

Estimating the sensitivity of genomic newborn screening for treatable inherited metabolic disorders

Impact of age at onset and newborn screening on outcome in organic acidurias

Establishment of an auxiliary diagnosis system of newborn screening for inherited metabolic diseases based on artificial intelligence technology and a clinical trial

Evaluating a Novel Newborn Screening Methodology: Combined Genetic and Biochemical Screenings

Two inborn errors of metabolism in a newborn: glutaric aciduria type I combined with isobutyrylglycinuria